Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice

被引:37
作者
Staropoli, I [1 ]
Frenkiel, MP [1 ]
Megret, F [1 ]
Deubel, V [1 ]
机构
[1] INST PASTEUR, UNITE ARBOVIRUS & VIRUS FIEVRES HEMORRAG, F-75724 PARIS 15, FRANCE
关键词
dengue virus; purified envelope protein; baculovirus; vaccine development;
D O I
10.1016/S0264-410X(97)00128-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We constructed a recombinant baculovirus which produces a dengue (DEN)-2 virus envelope (E) protein containing a six-histidine (H6) tag in place of the last 100 amino acids at its C-terminus. The recombinant protein was purified from the supernatant of baculovirus-infected Spodoptera frugiperda insect cell cultures to apparent homogeneity by cation-chelation chromatography (TALON(TM)) in which the H-6-tagged E-protein was eluted under non-denaturing conditions with 100 mM imidazole at pH 8.0. Mice vaccinated with the purified E mixed with aluminium hydroxide adjuvant showed an immune response of IgM and IgG1, IgG2a and IgG2b isotypes, and neutralizing antibodies, similar to that following immunization with purified inactivated DEN-2 virus. Moreover, mice that received the purified recombinant protein were significantly protected against 200 50% lethal dose of DEN-2 virus. This combination of affinity purified H-6-tagged protein and adsorption onto a cationic carrier seems promising for the production of immunogenic particulate proteins, especially DEN protein for the four serotypes, and the development of a new generation of vaccines. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:1946 / 1954
页数:9
相关论文
共 63 条
[1]   SYNTHESIS AND SECRETION OF RECOMBINANT TICK-BORNE ENCEPHALITIS-VIRUS PROTEIN-E IN SOLUBLE AND PARTICULATE FORM [J].
ALLISON, SL ;
STADLER, K ;
MANDL, CW ;
KUNZ, C ;
HEINZ, FX .
JOURNAL OF VIROLOGY, 1995, 69 (09) :5816-5820
[2]   CORRELATION OF E-PROTEIN BINDING WITH CELL SUSCEPTIBILITY TO DENGUE-4 VIRUS-INFECTION [J].
ANDERSON, R ;
KING, AD ;
INNIS, BL .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :2155-2159
[3]   ADJUVANTS - CURRENT STATUS, CLINICAL PERSPECTIVES AND FUTURE-PROSPECTS (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 174-178, 1993) [J].
AUDIBERT, FM ;
LISE, LD .
IMMUNOLOGY TODAY, 1993, 14 (06) :281-284
[4]   Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: Predominance of a Th2-biased pattern which persists after adult boosting [J].
Barrios, C ;
Brawand, P ;
Berney, M ;
Brandt, C ;
Lambert, PH ;
Siegrist, CA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) :1489-1496
[5]  
BRETT SJ, 1993, IMMUNOLOGY, V80, P306
[6]   DENGUE VIRUS-SPECIFIC CROSS-REACTIVE CD8+ HUMAN CYTO-TOXIC T-LYMPHOCYTES [J].
BUKOWSKI, JF ;
KURANE, I ;
LAI, CJ ;
BRAY, M ;
FALGOUT, B ;
ENNIS, FA .
JOURNAL OF VIROLOGY, 1989, 63 (12) :5086-5091
[7]   IGG2A RESTRICTION OF MURINE ANTIBODIES ELICITED BY VIRAL-INFECTIONS [J].
COUTELIER, JP ;
VANDERLOGT, JTM ;
HEESSEN, FWA ;
WARNIER, G ;
VANSNICK, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (01) :64-69
[8]   ANALYSIS OF C-TERMINALLY TRUNCATED DENGUE-2 AND DENGUE-3 VIRUS ENVELOPE GLYCOPROTEINS - PROCESSING IN INSECT CELLS AND IMMUNOGENIC PROPERTIES IN MICE [J].
DELENDA, C ;
STAROPOLI, I ;
FRENKIEL, MP ;
CABANIE, L ;
DEUBEL, V .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :1569-1578
[9]   PROTECTIVE EFFICACY IN MICE OF A SECRETED FORM OF RECOMBINANT DENGUE-2 VIRUS ENVELOPE PROTEIN PRODUCED IN BACULOVIRUS-INFECTED INSECT CELLS [J].
DELENDA, C ;
FRENKIEL, MP ;
DEUBEL, V .
ARCHIVES OF VIROLOGY, 1994, 139 (1-2) :197-207
[10]   RECOMBINANT BACULOVIRUSES EXPRESSING YELLOW-FEVER VIRUS-E AND NS1 PROTEINS ELICIT PROTECTIVE IMMUNITY IN MICE [J].
DESPRES, P ;
DIETRICH, J ;
GIRARD, M ;
BOULOY, M .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :2811-2816